Application no. and date | 13714618.9 (espacenet) (Federated) (European Patent Register), 20130402 | Patent/reg. no. and date | DK/EP 2833864, 20181219 | Publication date | 20150211 | Priority no. and date | EP 12163078, 20120404 | EP pub. no. and date |
EP 2833864 20150211 | Effective date | | Applicant/owner | Alkahest, Inc., 125 Shoreway Road, Suite D
San Carlos, CA 94070, US | Applicant ref. no. | BBS116629EPDK | Inventor | FETSCHER, Alfred, Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein, DE, SCHER, Jochen Matthias, Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein, DE | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | Opponent | | IPC Class | A61K 31/4545 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61K 9/48 (2006.01) , A61P 29/00 (2006.01) | Title | FARMACEUTISKE FORMULERINGER OMFATTENDE CCR3-ANTAGONISTER | Int. application no. | EP2013056867 | Int. publication no. | WO2013149987 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|